 Loughborough, England, June 30, 2021 GLOBE NEWSWIRE -- Nemaura Medical, Inc. NASDAQ: NMRD Nemaura or the Company, a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announces a presentation referring to its licensed Why WAIT program at the American Diabetes Associations 81st Annual Scientific Sessions. 